Abstract
We have previously described nanocomposites containing conjugates or complexes of native oligodeoxyribonucleotides with poly-L-lysine and TiO2 nanoparticles. We have shown that these nanocomposites efficiently suppressed influenza A virus reproduction in MDCK cells. Here, we have synthesized previously undescribed nanocomposites that consist of TiO2 nanoparticles and polylysine conjugates with oligonucleotides that contain phosphoryl guanidine or phosphorothioate internucleotide groups. These nanocomposites have been shown to exhibit antiviral activity in MDCK cells infected with H5N1 influenza A virus. The nanocomposites containing phosphorothioate oligonucleotides inhibited virus replication ~130-fold. More potent inhibition, i.e., ~5000-fold or ~4600-fold, has been demonstrated by nanocomposites that contain phosphoryl guanidine or phosphodiester oligonucleotides, respectively. Free oligonucleotides have been nearly inactive. The antiviral activity of oligonucleotides of all three types, when delivered by Lipofectamine, has been significantly lower compared to the oligonucleotides delivered in the nanocomposites. In the former case, the phosphoryl guanidine oligonucleotide has appeared to be the most efficient; it has inhibited the virus replication by a factor of 400. The results make it possible to consider phosphoryl guanidine oligonucleotides, along with other oligonucleotide derivatives, as potential antiviral agents against H5N1 avian flu virus.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- DMAPO:
-
4-dimethylaminopyridin N-oxide
- Dmi:
-
1,3-dimethyl-2-imidazolidineimino group
- TiO2 · PL-PO:
-
TiO2 · PL-PS, or TiO2 · PL-PG, nanocomposites consisting of TiO2 nanoparticles and polylysine conjugates with phosphodiester (PO), phosphoryl guanidine (PG), or phosphorothioate (PS)
References
Belikova A.M., Zarytova V.F., Grineva N.I. 1967. Synthesis of ribonucleosides and diribonucleoside phosphates containing 2-chloroethylamine and nitrogen mustard residues. Tetrahedron Lett. 37, 3557–3562.
Zamecnik P., Stephenson M. 1978. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc. Natl. Acad. Sci. U. S. A. 75, 280–284.
Roehr B. 1998. Fomivirsen approved for CMV retinitis. J. Int. Assoc. Physicians AIDS Care. 4, 14–16.
Juliano R.L., Ming X. Nakagawa O. 2012. Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides. Bioconjugate Chem. 23, 147–157.
Parveen S., Misra R., Sahoo S.K. 2012. Nanoparticles: A boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine. 8, 147–166.
Levina A., Ismagilov Z., Repkova M., Shikina N., Baiborodin C.I., Shatskaya N.V., Zagrebelnyi S.N., Zarytova V.F. 2013. Design of TiO2~DNA nanocomposites for penetration into cells. Russ. J. Bioorg. Chem. 39 (1), 77–86.
Levina A., Ismagilov Z., Repkova M., Shatskaya N., Shikina N., Tusikov F., Zarytova V. 2012. Design of nanocomposites consisting of titanium dioxide nanoparticles and oligonucleotides. J. Nanosci. Nanotechnol. 12, 1812–1820.
Levina A.S., Repkova M.N., Ismagilov Z.R., Shikina N.V., Malygin E.G., Mazurkova N.A., Zinov’ev V.V., Evdokimov A.A., Baiborodin S.I., Zarytova V.F. 2012. High-performance method for specific effect on nucleic acids in cells using TiO2~DNA nanocomposites. Sci. Rep. 2, e756.
Levina A.S., Repkova M.N., Mazurkova N.A., Makarevich E.V., Ismagilov Z.R., Zarytova V.F. 2015. Knockdown of different influenza A virus subtypes by a single antisense oligodeoxyribonucleotide. Int. J. Antimicrob. Agents. 46, 125–128.
Levina A.S., Repkova M.N., Bessudnova E.V., Filippova E.I., Mazurkova N.A., Zarytova V.F. 2016. High antiviral effect of TiO2·PL-DNA nanocomposites targeted to conservative regions of (–)RNA and (+)RNA of influenza A virus in cell culture. Beilstein J. Nanotechnol. 7, 1166–1173.
Stetsenko D.A., Kupryushkin M.S., Pyshnyi D.V. 2014. Patent Application WO2016/028187 A1. Priority from August 22, 2014.
Kitamura M., Yano M., Tashiro N., Miyagawa S., Sando M., Okauchi T. 2011. Direct synthesis of organic azides from primary amines with 2-azido-1,3-dimethylimidazolinium hexafluorophosphate. Eur. J. Org. Chem. 3, 458–462. doi 10.1002/ejoc.201001509
Levina A.S., Mikhalieva E.A., Repkova M.N., Zarytova V.F. 2008. Synthesis of polyamine-containing oligonucleotides. Russ. J. Bioorg. Chem. 34, 89–95.
Virology: A Practical Approach. Mahy B.W.J., Ed., Oxford: IRL, 1985; Moscow: Mir, 1988.
Zaks L. 1976. Statisticheskoe otsenivanie (Statistical Evaluation). Moscow: Statistika.
Portela A., Digard P. 2002. The influenza virus nucleoprotein: A multifunctional RNA-binding protein pivotal to virus replication. J. Gen. Virol. 83, 723–734.
Kupryushkin M.S., Pyshnyi D.V., Stetsenko D.A. 2014. Phosphoryl Guanidines: A new type of nucleic acid analogues. Acta Naturae. 6, 123–125.
Furuse Y., Oshitani H. 2011. Evolution of the influenza A virus untranslated regions. Infect. Genet. Evol. 11, 1150–1154.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.S. Levina, M.N. Repkova, B.P. Chelobanov, E.V. Bessudnova, N.A. Mazurkova, D.A. Stetsenko, V.F. Zarytova, 2017, published in Molekulyarnaya Biologiya, 2017, Vol. 51, No. 4, pp. 717–723.
Rights and permissions
About this article
Cite this article
Levina, A.S., Repkova, M.N., Chelobanov, B.P. et al. Impact of delivery method on antiviral activity of phosphodiester, phosphorothioate, and phosphoryl guanidine oligonucleotides in MDCK cells infected with H5N1 bird flu virus. Mol Biol 51, 633–638 (2017). https://doi.org/10.1134/S0026893317040136
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893317040136